Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Rowan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|September 4, 2023
In moderate-to-severe Crohn disease, upadacitinib increased clinical remission at 12 and 52 wkCatherine Rowan
Current Opinion in Gastroenterology|June 28, 2022
The future of telemedicine and wearable technology in IBDCatherine Rowan, Robert Hirten
Health Progress (Saint Louis, Mo.)|December 8, 2007
Using investments to work for community health. Socially responsible investment programs help carry a faith-based messageDonna Meyer, Catherine Rowan
Midwifery|May 22, 2007
Midwives' reflections on their educational programme: a traditional or problem-based learning approach?Catherine Rowan, Chris McCourt, Sarah Beake
Expert Opinion on Pharmacotherapy|May 3, 2022
An overview of ozanimod as a therapeutic option for adults with moderate-to-severe active ulcerative colitisCatherine Rowan, Ryan Ungaro, Saurabh Mehandru, et al.
Gastroenterology Research and Practice|July 28, 2018
Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population SeroprevalenceCatherine Rowan, Ciaran Judge, Mary D Cannon, et al.
Inflammatory Bowel Diseases|April 9, 2024
Tofacitinib as a Rescue Therapy for Ulcerative Colitis in PregnancyCatherine Rowan, Fiona Yeaman, Kenneth Ernest-Suarez, et al.
Gastroenterology|November 20, 2018
Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel DiseasesBrona Wynne, Louise McHugh, Wei Gao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2020
Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1α response in ulcerative colitis patientsEric Brown, Catherine Rowan, Moritz J Strowitzki, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Alterations in serum and intestinal ACE2 in Inflammatory Bowel Disease and the impact of inflammationFiona Jones, Ciara Egan, Miriam Tosetto, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|September 4, 2023
In moderate-to-severe Crohn disease, upadacitinib increased clinical remission at 12 and 52 wkCatherine Rowan
Current Opinion in Gastroenterology|June 28, 2022
The future of telemedicine and wearable technology in IBDCatherine Rowan, Robert Hirten
Health Progress (Saint Louis, Mo.)|December 8, 2007
Using investments to work for community health. Socially responsible investment programs help carry a faith-based messageDonna Meyer, Catherine Rowan
Midwifery|May 22, 2007
Midwives' reflections on their educational programme: a traditional or problem-based learning approach?Catherine Rowan, Chris McCourt, Sarah Beake
Expert Opinion on Pharmacotherapy|May 3, 2022
An overview of ozanimod as a therapeutic option for adults with moderate-to-severe active ulcerative colitisCatherine Rowan, Ryan Ungaro, Saurabh Mehandru, et al.
Gastroenterology Research and Practice|July 28, 2018
Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population SeroprevalenceCatherine Rowan, Ciaran Judge, Mary D Cannon, et al.
Inflammatory Bowel Diseases|April 9, 2024
Tofacitinib as a Rescue Therapy for Ulcerative Colitis in PregnancyCatherine Rowan, Fiona Yeaman, Kenneth Ernest-Suarez, et al.
Gastroenterology|November 20, 2018
Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel DiseasesBrona Wynne, Louise McHugh, Wei Gao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2020
Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1α response in ulcerative colitis patientsEric Brown, Catherine Rowan, Moritz J Strowitzki, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Alterations in serum and intestinal ACE2 in Inflammatory Bowel Disease and the impact of inflammationFiona Jones, Ciara Egan, Miriam Tosetto, et al.
Pageof 2